Skip to main content

Advertisement

Log in

Surgical management in intestinal Crohn’s disease

  • Clinical Review
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

The main strategy in surgical treatment of Crohn’s disease is resection of the diseased segment, despite possible development of postoperative nutritional impairment and lowered quality of life (QOL) caused by short bowel syndrome and early postoperative relapse. To overcome postoperative short bowel syndrome, minimal resection is highly recommended, and furthermore strictureplasty is now used in many institutions. Many reports have shown that strictureplasty is safe, has a low rate of surgical complications, and displays identical surgical results as intestinal resection. To apply this procedure to various types of Crohn’s disease, different derivatives of this procedure, such as Heineke–Mikulicz, Finney, Jaboulay, and double Heineke–Mikulicz type, as well as side-to-side isoperistaltic strictureplasty have evolved. In performing strictureplasty, the severity of stenosis is more important than the length of the stricture, because a simple but long stricture can be easily managed by any method of this procedure. Further, it is necessary to investigate the surgical specimens via histopathological analysis of frozen section when neoplastic change is suspected. Now, functional end-to-end anastomosis using a linear stapler has become the most frequently used method in intestinal surgery. Many studies have documented less leakage, morbidity, and anastomotic recurrence as well as shorter hospital stay following stapled anastomosis. As part of the postoperative maintenance treatment regimen, various drugs, such as masalamine, immunomodulators, and infliximab, have been shown to demonstrate positive efficacy when used solely or in combination. Endoscopic examination should be done regularly, and the maintenance treatment regimen should be adjusted according to the disease activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.

    Article  PubMed  Google Scholar 

  2. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology. 1993;105:1716–23.

    CAS  PubMed  Google Scholar 

  3. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut. 2005;54:237–41.

    Article  CAS  PubMed  Google Scholar 

  4. Lee ECG, Papaioannou N. Minimal Surgery for chronic obstruction in patients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl. 1982;64:229–33.

    CAS  PubMed  Google Scholar 

  5. Dehn TCB, Kettlewell MGW, Mortensen NJM, Lee ECG, Jewell DP. Ten-year experience of strictureplasty for obstructive Crohn’s disease. Br J Surg. 1989;76:339–41.

    Article  CAS  PubMed  Google Scholar 

  6. Sayfan J, Wilson DAL, Allan A, Andrew H, Alexander-Williams J. Recurrence after strictureplasty or resection for Crohn’s disease. Br J Surg. 1989;76:335–8.

    Article  CAS  PubMed  Google Scholar 

  7. Sharif H, Alexander-Williams J. The role of strictureplasty in Crohn’s disease. Int Surg. 1992;77:15–8.

    CAS  PubMed  Google Scholar 

  8. Hurst RD, Michelassi F. Strictureplasty for Crohn’s disease: techniques and long-term results. World J Surg. 1998;22:359–63.

    Article  CAS  PubMed  Google Scholar 

  9. Fazio VW, Galandiuk S, Jagelman DG, Lavery IC. Strictureplasty in Crohn’s disease. Ann Surg. 1989;210:621–5.

    Article  CAS  PubMed  Google Scholar 

  10. Fazio VW, Tjandra JJ. Strictureplasty for Crohn’s disease with multiple long stricture. Dis Colon Rectum. 1993;36:71–2.

    Article  CAS  PubMed  Google Scholar 

  11. Sasaki I, Funayama Y, Naito H, Fukushima K, Shibata C, Matsuno S. Extended strictureplasty for multiple skipped strictures of Crohn’s disease. Dis Colon Rectum. 1996;39:342–4.

    Article  CAS  PubMed  Google Scholar 

  12. Michelassi F. Side-to-side isoperistaltic strictureplasty for multiple Crohn’s strictures. Dis Colon Rectum. 1996;39:345–9.

    Article  CAS  PubMed  Google Scholar 

  13. Stebbing JF, Jewell DP, Kettlewell MGW, Mortensen NJM. Long-term results of recurrence and reoperation after strictureplasty for obstructive Crohn’s disease. Br J Surg. 1995;82:1471–4.

    Article  CAS  PubMed  Google Scholar 

  14. Ozuner G, Fazio VW, Lavery IC, Milsom JW, Strong S. Reoperative rates for Crohn’s disease following strictureplasty. Long-term analysis. Dis Colon Rectum. 1996;39:1199–203.

    Article  CAS  PubMed  Google Scholar 

  15. Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP. Mortensen NJM: long-term follow-up of strictureplasty for Crohn’s disease. Br J Surg. 2006;93:475–82.

    Article  CAS  PubMed  Google Scholar 

  16. Michelassi F, Hurst RD, Melis M, Rubin M, Cohen R, Gasparitis A, et al. Side-to-side isoperistaltic strictureplasty in extensive Crohn’s disease: a prospective longitudinal study. Ann Surg. 2000;232:401–8.

    Article  CAS  PubMed  Google Scholar 

  17. Funayama Y, Fukushima K, Shibata C, Takahashi K, Ogawa H, Sasaki I. Current status and results of strictureplasy for obstructive Crohn’s disease (in Japanese). J Jpn Soc Coloproctol. 2005;58:891–6.

    Google Scholar 

  18. Marchetti F, Fazio VW, Ozuner G. Adenocarcinoma arising from a strictureplasty site in Crohn’s disease. Report of a case. Dis Colon Rectum. 1996;39:1315–21.

    Article  CAS  PubMed  Google Scholar 

  19. Jaskowiak NT, Michelassi F. Adenocarcinoma at a strictureplasty site in Crohn’s disease. Report of a case. Dis Colon Rectum. 2001;44:284–6.

    Article  CAS  PubMed  Google Scholar 

  20. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL. Coremans G: natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–72.

    Article  CAS  PubMed  Google Scholar 

  21. Moskovitz D, McLeod RS, Greenberg GR, Cohen Z. Operative and environmental risk factors for recurrence of Crohn’s disease. Int J Colorectal Dis. 1999;14:224–6.

    Article  CAS  PubMed  Google Scholar 

  22. Tersigni R, Alessandroni L, Barreca M, Piovanello P, Prantera C. Does stapled functional end-to-end anastomosis affect recurrence of Crohn’s disease after ileocolonic resection? Hapatogastroenterology. 2003;50:1422–5.

    Google Scholar 

  23. Simillis C, Purkayastha S, Yamamoto T, Strong S, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum. 2007;50:1674–87.

    Article  PubMed  Google Scholar 

  24. Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MRB. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn’s disease. Scand J Gastroenterol. 1999;34:708–13.

    Article  CAS  PubMed  Google Scholar 

  25. Ikeuchi H, Kusunoki M, Yamamura T. Long-term results of stapled and hand-sewn anastomosis in patients with Crohn’s disease. Dig Surg. 2000;17:493–6.

    Article  CAS  PubMed  Google Scholar 

  26. Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MRB. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn’s disease. Dis Colon Rectum. 2001;44:20–6.

    Article  CAS  PubMed  Google Scholar 

  27. Hashemi M, Novell JR, Lewis AAM. Side-to-side stapled anastomosis may delay recurrence in Crohn’s disease. Dis Colon Rectum. 1998;41:1293–6.

    Article  CAS  PubMed  Google Scholar 

  28. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H. European cooperative Crohn’s disease study (ECCDS): results of drug treatment. Gastroenterology. 1984;86:249–66.

    CAS  PubMed  Google Scholar 

  29. Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, Aerts R, et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology. 1995;108:1617–21.

    Article  CAS  PubMed  Google Scholar 

  30. D’Haens G, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology. 2008;135:1123–9.

    Article  PubMed  Google Scholar 

  31. McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O’Rourke K, Andrew DF, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology. 1995;109:404–13.

    Article  CAS  PubMed  Google Scholar 

  32. Camma C, Guinta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn’s disease: a meta-analysis adjusted for confounding variables. Gastroenterology. 1997;113:1465–73.

    Article  CAS  PubMed  Google Scholar 

  33. Lochs H, Mayers M, Fleig WE, Mortensen PB, Bauer P, Genser D, et al. Prophylaxis of postoperative relapse in Crohn’s disease with mesalamine: European cooperative Crohn’s disease study VI. Gastroenterology. 2000;118:264–73.

    Article  CAS  PubMed  Google Scholar 

  34. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, et al. Post-operative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a two year trial. Gastroenterology. 2004;127:723–9.

    Article  CAS  PubMed  Google Scholar 

  35. Ardizzone S, Maconi G, Sampierto GM, Russo A, Radice E, Colombo E, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology. 2004;127:730–40.

    Article  CAS  PubMed  Google Scholar 

  36. Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Iwabuchi M, et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease; a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24:1333–40.

    Article  CAS  PubMed  Google Scholar 

  37. Regueiro M, Schrout W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136:441–50.

    Article  CAS  PubMed  Google Scholar 

  38. Blum E, Katz JA. Postoperative therapy for Crohn’s disease. Inflamm Bowel Dis. 2009;15:463–72.

    Article  PubMed  Google Scholar 

  39. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–63.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuji Funayama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Funayama, Y., Takahashi, Ki. & Sasaki, I. Surgical management in intestinal Crohn’s disease. Clin J Gastroenterol 3, 1–5 (2010). https://doi.org/10.1007/s12328-009-0129-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-009-0129-1

Keywords

Navigation